Key clinical point: DaxibotulinumtoxinA for Injection (DAXI) appears to be safe and effective for treatment of dynamic forehead lines.

Major finding: Four weeks after treatment with the investigational neuromodulator, no or only mild forehead lines were present in 86%-100% of patients, depending upon the received dose.

Study details: This phase 2 study included 61 adults with moderate or severe dynamic forehead lines and glabellar lines who received one of four doses of DAXI.

Disclosures: The presenter reported serving as a paid investigator for Revance Therapeutics, the study sponsor.